Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Will P&G Pharma Auction End the Company's Pursuit of "Viagra for Women"?
- Procter & Gamble's desire to get out of the prescription pharmaceutical business either by selling its brands or managing them through their natural declines raises the question of whether this will finally kill P&G's longtime, ill-fated interest in creating a version of Viagra for women. BNET readers will remember that...
- Blog posts 2008-12-11
Additional Resources
- Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Certainly. Ladies and gentlemen, at this time, we'll be conducting the question-and-answer session. Operator instructions. Our first question will come from Patti Bank with Pacific Growth Equities. Patti Bank – Pacific Growth Equities Thanks for the update information, it was very helpful. Just two questions, one on...
- Earnings calls 2008-11-24
- Noven to File Form 12b-25 to Extend Filing Date of 2007 Form 10-K
- Noven Postpones Earnings Announcement and Related Analyst Conference Call Noven Provides Preliminary Unaudited Financial Information MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that, for the reasons described below, it intends to file a Form 12b-25 with the United States Securities and Exchange Commission (the "SEC"), which will...
- Research articles 2008-03-12
- Noven Provides Update on Developmental Fentanyl Patch
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food & Drug Administration ("FDA") has advised Noven that the FDA does not expect to approve Noven's Abbreviated New Drug Application ("ANDA") for a generic version of DuragesicR fentanyl transdermal system, and has ceased its review of the ANDA,...
- Research articles 2005-09-28
- Noven to Present at UBS Global Life Sciences Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert Strauss, Noven's President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the UBS Global Life Sciences Conference in New York City on Tuesday, September 25th at 8:00 a.m. ET. The public is invited...
- Research articles 2007-09-20
- Noven and P&G Try "Viagra for Women" Despite History of Failure
- Yet another company is taking a crack at the "Viagra for women" concept. This time it is Noven Pharmaceuticals, which has licensed its testosterone-based skin patch to Procter & Gamble. The companies did not disclose the terms of the deal. The move is an interesting one for...
- Blog posts 2008-08-22
- Noven Pharmaceuticals to Present at Bear Stearns Healthcare Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (Nasdaq:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to present an update on Noven's business and prospects on Monday, September 13, 2004 at 11:30 a.m. Eastern Time at the Bear Stearns 17th Annual Healthcare Conference in New York. A...
- Research articles 2004-09-08
- Noven Named Transdermal Drug Delivery Company of the Year by Frost & Sullivan
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the global growth consulting company Frost & Sullivan has named Noven its 2006 Transdermal Drug Delivery Company of the Year, citing the competitive advantages of Noven's patented DOT Matrix[TM] transdermal technology, the continued success of its commercialized transdermal systems, and its...
- Research articles 2006-11-02
- Noven to Report 2007 Fourth Quarter and Full Year Financial Results and Host Conference Call on March 27, 2008
- SEC Comment Resolved, Noven to Maintain Current Revenue Recognition Policy MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that it will release its 2007 fourth quarter and full year financial results before the market opens on Thursday, March 27, 2008. Noven management will host a conference call that same...
- Research articles 2008-03-24
- Noven Announces 2008 First Quarter Earnings Release Date
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced its 2008 first quarter earnings release date. Separately, Noven also announced an upcoming investor presentation. On May 8, 2008, before the U.S. market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended...
- Research articles 2008-05-05
- Study: P&G's Intrinsa Doesn't Work; Reflects Badly on Noven and Pharma Unit Sale
- More bad news for Procter & Gamble Pharmaceuticals: a study review found that its sex-drive-enhancer for women, Intrinsa, doesn't work and its safety record is in doubt. This will not reflect well on Noven, which last year entered a partnership with P&G to boost the packaged-goods company's...
- Blog posts 2009-03-05
- Noven to Present at UBS Global Specialty Pharmaceuticals Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the UBS Global Specialty Pharmaceuticals Conference in New York on Monday, April 24, 2006, at 2:30 p.m. Eastern Time. The public...
- Research articles 2006-04-20
- Noven to Present at Lehman Brothers Global Healthcare Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the Lehman Brothers Tenth Annual Global Healthcare Conference in Miami Beach on Wednesday, March 21, 2007, at 10:45 a.m. Eastern Time....
- Research articles 2007-03-14
- Noven to Present at Deutsche Bank Annual Health Care Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the Deutsche Bank Annual Health Care Conference in Boston on Wednesday, May 3, 2006, at 2:30 p.m. Eastern Time. The public...
- Research articles 2006-04-27
- Noven to Present at Deutsche Bank Annual Health Care Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the 32nd Annual Deutsche Bank Health Care Conference in Washington, DC on Wednesday, May 2, 2007, at 9:00 a.m. Eastern Time....
- Research articles 2007-04-25
- Noven to Present at UBS Global Generic and Specialty Pharmaceuticals Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the UBS Global Generic and Specialty Pharmaceuticals Conference in New York City on Wednesday, May 9, 2007, at 9:30 a.m. Eastern...
- Research articles 2007-05-03
- Noven to Present at UBS Global Life Sciences Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the UBS Global Life Sciences Conference in New York on Wednesday, September 27, 2006, at 8:30 a.m. Eastern Time. The public...
- Research articles 2006-09-21
- Noven to Present at Deutsche Bank Small Cap Growth Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven's business and prospects at the Deutsche Bank Small Cap Growth Conference in Naples, Florida on Tuesday, February 13, 2007, at 12:00 noon Eastern Time. The...
- Research articles 2007-02-06
- Noven to Present at Banc of America Securities Specialty Pharmaceuticals Conference
- MIAMI -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that company representatives are scheduled to present at the Banc of America Securities Specialty Pharmaceuticals Conference in Southampton, New York, on Thursday, July 28, 2005 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be accessible to the public...
- Research articles 2005-07-25
- Noven appoints Jane Poppelreiter senior director of Sales
- MIAMI--BUSINESS WIRE--Sept. 5, 1996--Noven Pharmaceuticals Inc. (NASDAQ:NOVN) announced Thursday that Jane Poppelreiter has been appointed to the newly created position of senior director of Sales.Poppelreiter has been a consultant with Noven for the past year, and will now continue this arrangement on a full time basis. Her role at...
- Research articles 1996-09-05
- << Previous
- page 1 of 1
- Next >>
